|
|
News
Teresa Leezer Honored a Second Time for Excellence in Business Management
Teresa M. Leezer, Vice President of MetaCyte Business Lab LLC, has been included in the 2010 Cambridge Who's Who in Business Managment, an honor she first won in 2009, when she was named the Cambridge Who's Who Executive of the Year. The Cambridge Who's Who selection committee chooses these special honorees based on their accomplishments, academic achievements, leadership and service.
Teresa has more than 15 years of executive management experience from Fortune 100 pharmaceutical companies including Hoffman-LaRoche, Merck Labs and Bristol Myers Squibb respectively. Her experience includes the management of business units, portfolios and products in every phase of the life cycle - from pre-clinical, to launch, growth and maturity. Her sales, marketing and management expertise spans the institutional, physician and over the counter markets. Estimated launch product sales exceed $7 billion including worldwide blockbusters such as Fosamax, Zantac, Reyataz, Sustiva, Aleve and Rocephin.
Teresa's expertise includes over ten categories of medicine: osteoporosis, oncology, virology, anti-infectives, rheumatology, anesthesiology, dermatology, and pain management. She has directed significant co-marketing initiatives including the co-promotion of Zantac with Roche and Glaxo and the co-promotion of Fosamax with Merck and Wyeth-Ayerst. Teresa has also managed contract sales organizations for the promotion of products such as Flonase and Aleve.
MetaCyte Business, Lab, LLC is a life and health science business incubator that creates and launches new companies from promising health science technologies. Ms. Leezer notes that the most rewarding aspect of her career is helping to make a difference in the world with novel ideas and technology.
Ms. Leezer is the project director for the following MetaCyte portfolio companies: AllTranz, AppoImmune, Innorem and RhinoCyte. She also serves on the management team for Pradama. She has secured development capital in excess of $10M from venture, federal and angel financing.
Teresa received a Bachelor of Applied Science and a Masters of Business Administration from the University of Louisville. She attended City University, London, England. Teresa has completed Executive Management Programs at Columbia University and the University of Pennsylvania Wharton School of Business.
Teresa currently serves on the Board of Directors for RhinoCyte, Inc., the Board of Directors for AllTranz, Inc., the LouHie Board of Directors, the Ronald McDonald House Board of Directors and the St. Francis of Assisi School Board.
|
|
